Q2 2022 Holdings
Filed 2022-08-15 | 22 holdings | $22.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $14.9M | 39,370 | 65.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.7M | 857,352 | 34.0% |
| Medavail Holdings Inc | COM | 58406B103 | $9.0K | 5,894,897 | 0.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $7.6K | 115,000 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $6.5K | 160,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $6.3K | 650,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $5.9K | 700,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $5.7K | 496,012 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $4.5K | 181,500 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $4.5K | 170,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $4.4K | 250,000 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $3.7K | 1,137,152 | 0.0% |
| Isoplexis Corp | COM | 465005106 | $3.6K | 1,650,118 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $3.3K | 735,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $3.2K | 3,364,895 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $3.2K | 207,290 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $3.0K | 160,000 | 0.0% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $3.0K | 699,664 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $2.9K | 1,080,566 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $2.8K | 1,410,155 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.3K | 175,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $1.7K | 550,000 | 0.0% |